Celltrion said it would change its strategy for developing a Covid-19 treatment to respond to the rapidly changing pandemic situations after the emergence of the Omicron variant.For instance, the company will scrap its plan to develop an inhaled cocktail antibody treatment that adds CT-P63, a candid
“The paradigm in healthcare services shifted toward patient-centered care. As a result, the results of patient experience evaluation will directly affect the profits of medical institutions and all medical indices. Therefore, patient experience evaluation will grow more in the future.”So said Kim Sa
GI Innovation said it obtained a substance patent of GI-101, its key immunotherapy candidate, in the U.S.On Monday, the company said it registered the GI-101 patent with a wide range of rights without amino sequence restrictions in the U.S. which accounts for 60 percent of the global biopharmaceutic
Seegene said Tuesday it has developed a diagnostic reagent for the monkeypox virus, Novaplex MPXV Assay, using its AI-based automatic reagent development system, Seegene Digitalized Development System (SGDDS).Since the first discovery of the monkeypox virus in the U.K. last month, the African endemi
The Ministry of Food and Drug Safety (MFDS) said Tuesday it has developed a pulse wave simulation device by applying "human body-imitating technology" to minimize device errors in sphygmographs that measure blood vessel pulsation.A pulse meter measures pulses in blood vessels to predict vascular sti
Dae Hwa Pharm said it applied to the drug regulator for a change in the post-marketing surveillance (PMS) plan for Liporaxel (ingredient: paclitaxel), chemotherapy to extend the September deadline of the drug re-evaluation.The Ministry of Food and Drug Safety’s central pharmaceutical review committe
BL, a new drug developer, said Monday that it has obtained approval for administering patients with BLS-H01, a drug aimed at treating all Covid-19 variants.The Institutional Review Board (IRB) of Gachon University Gil Medical Center approved the phase 2 clinical trial of BLS-H01, a medication for Co
Korea’s new Covid-19 cases hit the lowest level in five-and-a-half months on Monday. However, experts warned a possible resurge this summer could be worse than last year’s, noting the nation has lifted almost all restrictions.The nation’s new virus cases fell below 3,500 on Monday as the Covid-19 pa
“In conducting this study, I met many insiders of the active pharmaceutical ingredient (API) industry, and most of them said, ‘We are like abandoned children,’ or ‘Everyone knows that the pharmaceutical industry can hardly move forward without a competitive API sector. Unfortunately, however, the go
Kalos Medical said Monday that it would start recruiting patients for exploratory clinical trials of DENEX, Korea's first hypertension treatment medical device, in four European countries.The company will conduct the clinical trial at 21 institutions in Greece, Germany, Italy, and Poland, by recruit
A group of nephrologists at Seoul National University Bundang Hospital (SNUBH) has built a model to evaluate the nephrotoxicity of computerized tomography (CT) contrast agents, using 3D tissue chip technology.The research team, led by Professor Kim Se-joong of the Nephrology Department, created a hu
The number of medical tourists visiting Korea expanded 24.6 percent year-on-year in 2021, despite the Covid-19 pandemic, government data showed.However, foreign patients seeking dermatology care decreased, and the proportion of medical tourists visiting the Seoul metropolitan area also fell last yea
The Ministry of Food and Drug Safety released the results of the expert review on SK Bioscience’s SKYCovione (pipeline name: GBP510), the nation’s first homegrown Covid-19 vaccine, and said the data was sufficient to confirm approval.However, some criticized the government, saying it unfairly and pr
The Yonsei University College of Medicine (YUCM)’s Institute of Tropical Medicine hosted the 45th Tropical Medicine Symposium as an online meeting on Saturday to discuss ways to respond to various infectious diseases.Six infectious disease experts gave lectures to about 50 participants on global hea
The government has included vaccines and other biopharmaceutical technologies into its list of core strategy technology to produce raw materials, parts, and equipment, drawing keen attention from related industries.Last Thursday, the Ministry of Trade, Industry and Energy said it would add four biop
Chinese pharmaceutical companies, including Antengene, Everest Medicines, and BeiGene, established Korean offshoots recently. Unlike other Chinese companies that used to export drug ingredients to Korea, these companies aim to target the Korean market with innovative drugs for serious diseases like
The declining pace of Covid-19 cases has slowed somewhat in Korea due partly to the largest inflows from abroad since March, quarantine officials said Friday.Among the 7,227 newly confirmed cases on Friday, 111 cases – 71 Koreans and 40 foreigners -- came from abroad, an increase of 19 from the prev
The organizers of the first International Virus and Bacterial Industry Expo in Korea have recently signed a business agreement with the Association of American States Offices in Korea (ASOK) for the successful hosting of the event.The Int’l Virus & Bacteria Industry Expo is the first such event to b
VT BIO said the company received approval to conduct clinical trials of its VT301 drug to treat Alzheimer's disease of antigen-specific self-regulated T cells by the U.S. Food and Drug Administration on Thursday.This U.S. clinical trial is the second one to treat Alzheimer's disease using regulated
Celltrion Healthcare has started a study to evaluate the effect of replacing Humira (ingredient: adalimumab), an autoimmune disease treatment developed by AbbVie, with Yuflyma in France.According to Clinicaltrials.gov, a clinical information site run by the U.S. National Institutes of Health, Celltr